Suchergebnisse - (Person:"Liu, Binliang")

PubPharm (2)

1

Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Yi, Z. | Liu, B. | Sun, X. | +10

2

Everolimus in hormone receptor-positive metastatic breast cancer : PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study

enthalten in: BMC cancer | 2019

von Yi, Z. | Ma, F. | Liu, B. | +5

1
[1]